Showing posts with label explain. Show all posts
Showing posts with label explain. Show all posts

Tuesday, 20 August 2013

Copper build up in brain 'could explain Alzheimer's dementia'

Featured Article
Academic Journal
Main Category: Alzheimer's / Dementia
Also Included In: Neurology / Neuroscience;  Water - Air Quality / Agriculture
Article Date: 20 Aug 2013 - 3:00 PDT Current ratings for:
Copper build up in brain 'could explain Alzheimer's dementia'
not yet ratednot yet rated

New research suggests copper that enters the body at levels encountered in the average modern diet may be leading, eventually, to Alzheimer's disease - by reducing the body's ability to clear away toxic proteins in the brain, and also by encouraging the clumping of those proteins.

Copper is an essential trace element in the diet. With iron, it helps make red blood cells, and it is also essential for the health of the immune system, blood vessels, nerves, and bones.

Copper enters the body via many sources, including drinking water carried in copper pipes, and from foods such as shellfish, nuts, red meat and many fruits and vegetables, and also via food supplements.

But now a study that used cells from both mice and humans, led by Rashid Deane, a research professor in the University of Rochester Medical Center (URMC) in the US, shows that copper can also build up in the brain and disrupt the body's ability to clear away amyloid beta proteins before they form the plaques that are the hallmark Alzheimer's disease.

Prof Deane says:

"It is clear that, over time, copper's cumulative effect is to impair the systems by which amyloid beta is removed from the brain."

He and his co-authors, all with URMC, write about their findings in Monday's online issue of the Proceedings of the National Academy of Sciences.

Normally, the body removes amyloid beta from the brain with the help of a protein called LRP1, short for lipoprotein receptor-related protein 1. This protein, which lines blood vessels in the brain, binds with amyloid beta and escorts it out of the brain.

For their study, the team gave mice trace levels of copper for three months.

They found the metal collected in the cells walls of the fine vessels that feed blood to the brain.

The cells the copper collected in are an important part of the brain's defence mechanism, the so-called blood/brain barrier, which controls the substances that can pass in and out of brain tissue.

By collecting copper in their membranes, the cells were just doing their job.

But the researchers found that with time, through the process of oxidation, the copper build up in the cell walls started to affect the ability of LRP1 to escort amyloid beta proteins out of the brain. They saw this happen in both mouse and human brain cells.

In a further experiment, they then examined the process in live mice bred to develop Alzheimer's disease. They found the cells responsible for maintaining the blood/brain barrier could not cope: they became leaky, probably with age and repeated damage from toxins.

Had they not been leaky, the cells would have trapped the copper in their cell walls, but in the Alzheimer's mice, the blood-borne metal was able to pass unhindered through the blood/brain barrier.

As it met with brain tissue, the leaked copper stimulated brain cells to increase their production of amyloid beta.

The copper also had a direct effect on the toxic protein itself: it encouraged it to clump together and form the characteristic plaques of Alzheimer's disease.

Once amyloid beta forms these large clumps inside brain cells, the body's natural ways of eliminating it are overwhelmed and cannot cope: scientists believe this is how Alzheimer's starts and progresses.

In a final experiment, the team also found that copper led to inflammation of brain tissue, which may also speed up the breakdown of the blood/brain barrier and the subsequent build up of Alzheimer's toxins.

The levels of copper the researchers used in their experiments were trace amounts, about one-tenth of that set by standards for water quality from the US Environmental Protection Agency.

Prof Deane says:

"These are very low levels of copper, equivalent to what people would consume in a normal diet."

But neither he nor his colleagues are suggesting people change their diets or intakes of copper on the basis of these findings, which they say should be interpreted with caution.

The body needs copper, it is an essential metal. The effects shown in this study are due to exposure over a long period, and the key is getting the balance between too much and too little.

"Right now we cannot say what the right level will be, but diet may ultimately play an important role in regulating this process," Prof. Deane says.

Help with finding for the study came from The Alzheimer's Association, the National Institute on Aging, and a pilot grant from the National Institute of Environmental Health Sciences.

This is not the first study to implicate copper in a neurodegenerative disease. In 2011, another group of US researchers reported how copper affected a protein associated with Parkinson's disease.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our alzheimer's / dementia section for the latest news on this subject.

Low levels of copper disrupt brain amyloid-ß homeostasis by altering its production and clearance Itender Singh, Abhay Sagare, Mireia Coma and others, PNAS. Published online 19 August 2013 (DOI: 10.1073/pnas.1302212110).

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Paddock, Catharine. "Copper build up in brain 'could explain Alzheimer's dementia'." Medical News Today. MediLexicon, Intl., 20 Aug. 2013. Web.
20 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Copper build up in brain 'could explain Alzheimer's dementia''

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Monday, 19 August 2013

Genes discovered to explain high altitude disease

Featured Article
Academic Journal
Main Category: Genetics
Also Included In: Cardiovascular / Cardiology
Article Date: 19 Aug 2013 - 0:00 PDT Current ratings for:
Genes discovered to explain high altitude disease
not yet ratednot yet rated

Scientists say they have discovered why some humans develop chronic mountain sickness (CMS) while other people can adapt to high altitudes. According to a study published in the American Journal of Human Genetics, it is all in the genes.

Researchers from the University of California-San Diego (UCSD) say they have decoded a genetic basis for chronic mountain sickness, also known as Monge's disease, which could potentially lead to the development of new treatments.

The team conducted their research based on previous studies showing that many people who live in high-altitude regions, such as the Andes mountain region of South America, are not adapted to their environment and continue to suffer from CMS.

Around 140 million people have permanently settled within high-altitude regions, the researchers say. These environments have low-oxygen conditions, which can cause residents to suffer from hypoxia - low levels of oxygen in the blood, causing CMS.

CMS usually develops after spending an extended time living in altitudes over 3,000 meters. Symptoms include headache, depression, fatigue and sleepiness. People with the disease can often have strokes or heart attacks during early adulthood as a result of the decrease in oxygen getting to organs and tissues.

For the study, the researchers recruited 20 Peruvian residents of the Andes region: ten residents who suffered from CMS and ten residents without the disease. Their genetic variation was measured using whole genome sequencing.

Two genes were identified - ANP32D and SENP1. According to the study authors, both genes showed increased presence in residents who suffered from CMS, compared with those who did not have the disease.

The researchers looked to assess whether "down-regulating" these genes would limit the symptoms of hypoxia, and they looked at a species with corresponding gene sequences - the fruit fly.

Gabriel Haddad, distinguished professor and chair of the Department of Pediatrics at UCSD, explains:

"While a number of published articles have described an association between certain genes and the ability for humans to withstand low oxygen at high levels, it was very hard to be sure if the association was causal.

We found that flies with these genes down-regulated had a remarkably enhanced survival rate under hypoxia."

The researchers say that the findings in this study may lead to potential treatments, not only for those living at high altitudes, but also for those at any altitude who suffer from cardiovascular and brain diseases related to low oxygen levels.

Further research will involve conducting whole genome sequencing on 100 participants to determine if biomarkers - a substance used as an indicator of a biological state - exist to predict CMS.

The researchers have already taken skin samples from the 100 participants, which will be "reprogramed" into pluripotent stem cells (IPS). The study authors add that the IPS cells, if they have the capacity to become glia or red blood cells, may be used to "test the resilience to low oxygen levels."

Written by Honor Whiteman


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our genetics section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Whiteman, Honor. "Genes discovered to explain high altitude disease." Medical News Today. MediLexicon, Intl., 19 Aug. 2013. Web.
19 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Genes discovered to explain high altitude disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here